Micromet, Inc. , a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced that the company will conduct a conference call and audio webcast on Wednesday, August 8, 2007, at 9:00am Eastern Time in conjunction with the release of its financial results for the second quarter ended June 30, …
More: continued here